Detailed view for PVX_099565

Basic information

TDR Targets ID: 268349
Plasmodium vivax, OTU-like cysteine protease, putative
Source Database / ID:  PlasmoDB 

pI: 9.1095 | Length (AA): 216 | MW (Da): 25618 | Paralog Number: 0

Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0

Druggability Group : DG1

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF02338   OTU-like cysteine protease

Gene Ontology

Mouse over links to read term descriptions.
No GO information for this protein.

Metabolic Pathways

This gene is not mapped to any metabolic pathway in KEGG.

Structural information

Modbase 3D models:

There are 4 models calculated for this protein. More info on these models, including the models themselves is available at: Modbase

Target Beg Target End Template Template Beg Template End Identity Evalue Model Score MPQS zDope
1 216 1tff (A) 9 233 13.00 0 0.86 0.92 0.14
25 212 1tff (A) 30 229 17.00 0 0.7 0.93 -0.01
53 211 3tmp (A) 175 338 18.00 0 1 1.04351 -0.44
94 210 3tmp (G) 221 337 25.00 0.0000061 1 0.923867 -0.82

Help me make sense of these data.

Target Beg: first modeled residue
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)

A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.

PDB Structures:

No structure availble in the PDB for this protein

Expression

Upregulation Percent Ranking Stage Dataset
Upper 80-100% percentile intraerythrocytic - 24 hs, intraerythrocytic - 30 hs, intraerythrocytic - 36 hs. Zhu L
Upregulation Percent Ranking Stage Dataset
Upper 60-80% percentile intraerythrocytic - 6 hs, intraerythrocytic - 12 hs, intraerythrocytic - 18 hs, intraerythrocytic - 40 hs, intraerythrocytic - 48 hs. Zhu L
Show/Hide expression data references
  • Zhu L New insights into the Plasmodium vivax transcriptome using RNA-Seq.

Orthologs

Ortholog group members (OG5_133395)

Species Accession Gene Product
Cryptosporidium hominis Chro.60317   cysteine protease
Cryptosporidium parvum cgd6_2750   cysteine protease, putative
Leishmania braziliensis LbrM.34.1310   hypothetical protein, conserved
Leishmania donovani LdBPK_351400.1   Zn-finger in Ran binding protein and others/OTU-like cysteine protease, putative
Leishmania infantum LinJ.35.1400   hypothetical protein, conserved
Leishmania major LmjF.35.1390   hypothetical protein, conserved
Leishmania mexicana LmxM.34.1390   hypothetical protein, conserved
Neospora caninum NCLIV_027730   hypothetical protein
Plasmodium berghei PBANKA_0824000   OTU domain-containing protein, putative
Plasmodium falciparum PF3D7_0923100   OTU domain-containing protein, putative
Plasmodium knowlesi PKNH_0721100   OTU domain-containing protein, putative
Plasmodium vivax PVX_099565   OTU-like cysteine protease, putative
Plasmodium yoelii PY02414   hypothetical protein
Trypanosoma brucei gambiense Tbg972.5.1460   hypothetical protein, conserved
Trypanosoma brucei Tb927.5.1070   OTU-like cysteine protease, putative
Trypanosoma congolense TcIL3000_5_830   hypothetical protein, conserved
Trypanosoma cruzi TcCLB.511181.60   OTU-like cysteine protease, putative
Trypanosoma cruzi TcCLB.508301.10   OTU-like cysteine protease, putative
Toxoplasma gondii TGME49_258780   OTU family cysteine protease

Essentiality

PVX_099565 has one or more orthologs with essentiality data
Gene/Ortholog Organism Phenotype Source Study
Tb927.5.1070 Trypanosoma brucei significant gain of fitness in bloodstream forms (3 days) alsford
Tb927.5.1070 Trypanosoma brucei significant gain of fitness in bloodstream forms (6 days) alsford
Tb927.5.1070 Trypanosoma brucei no significant loss or gain of fitness in procyclic forms alsford
Tb927.5.1070 Trypanosoma brucei no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms alsford
PBANKA_0824000 Plasmodium berghei Slow plasmo
TGME49_258780 Toxoplasma gondii Probably non-essential sidik
Show/Hide essentiality data references
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924

Phenotypes and Validation (curated)

We have no manually annotated phenotypes for this target. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.

Annotated validation

No validation data for this target

Associated compounds / Druggability

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Non orthologous druggable targets
By sequence similarity to non orthologous druggable targets
No additional associated druggable targets
Obtained from network model
No druggable targets predicted through repurposing network model

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

No literature references available for this target.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier PVX_099565 (Plasmodium vivax), OTU-like cysteine protease, putative
Title for this comment
Comment